Skip to main content

letter

. 1993 Jun 5;306(6891):1543–1544. doi: 10.1136/bmj.306.6891.1543-c

Zidovudine unproved in AIDS dementia.

A Burgess, S Thornton, J Catalan

PMCID: PMC1677947 PMID: 8518705

1543

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Brunetti A., Berg G., Di Chiro G., Cohen R. M., Yarchoan R., Pizzo P. A., Broder S., Eddy J., Fulham M. J., Finn R. D. Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study. J Nucl Med. 1989 May;30(5):581–590. [PubMed] [Google Scholar]
Gazzard B. G. After Concorde. BMJ. 1993 Apr 17;306(6884):1016–1017. doi: 10.1136/bmj.306.6884.1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
Riccio M., Burgess A., Hawkins D., Wilson B., Thompson C. Neuropsychological and psychiatric changes following treatment of ARC patients with zidovudine. Int J STD AIDS. 1990 Nov;1(6):435–437. doi: 10.1177/095646249000100609. [DOI] [PubMed] [Google Scholar]
Schmitt F. A., Bigley J. W., McKinnis R., Logue P. E., Evans R. W., Drucker J. L. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med. 1988 Dec 15;319(24):1573–1578. doi: 10.1056/NEJM198812153192404. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES